Navigation Links
Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria
Date:7/22/2014

PITTSBURGH, July 22, 2014 /PRNewswire/ -- Hussey Copper, a leader in copper manufacturing and maker of MD-Cu29 antimicrobial copper announces Pullman Regional Hospital's conversion of more than 1,100 touch points to the first EPA-registered antimicrobial solid touch surface, at a nominal cost.  This reasonably priced surface kills greater than 99.9% of MRSA, E-coli and other bacteria within 2 hours of exposure1 and will aid the hospital in protecting against bacteria and infectious diseases in its facilities.

Pullman Regional Hospital, in Pullman, Wash., understands the bacteria-killing effects of antimicrobial copper and the benefits for its acute care.  Pullman's innovative initiatives are a living example of their commitment to health and tangible step toward its vision for a self-sustaining, self-determining inclusive model of healthcare.

MD-Cu29 antimicrobial copper delivers continuous and ongoing antibacterial action, remaining effective in killing greater than 99.9% of bacteria within 2 hours and continues to kill 99% of bacteria* even after repeated contaminations.

"Changing existing touch surfaces over to MD-Cu29 antimicrobial copper is not as expensive as you think. For less than $7,000, Pullman converted more than 1,100 touch surfaces to a material that is registered by the EPA to kill certain types of bacteria," said Joe Mallak, CEO of Hussey Copper. " Sustainable and attainable, how many products can you think of that are low in cost and kill bacteria like MRSA & E-coli and do so for the life of the product, even after repeated contaminations? "  

MD-Cu29 antimicrobial copper can be easily researched online at mdcu29.com or on amazon.com.  

About Pullman Regional Hospital
Pullman Regional Hospital is located in Pullman, Wash. and consists of a 95,000 square foot level IV trauma center with 25 patient beds, 3 ORs, and 24-hour emergency care, serving the Palouse region and beyond. Learn more about Pullman's innovative ways pullmanregional.org.

About Hussey Copper
Founded in 1848 and headquartered in Leetsdale, Pa., Hussey Copper was acquired by Lynn Tilton in 2011 and is the world's largest producer of electrical copper bar. Hussey Copper manufactures consistently high-quality coppers and copper-nickel alloys for a range of industries and applications. Information about Hussey Copper is available at husseycopper.com.  Information about Lynn Tilton is available at patriarchpartners.com.

1Laboratory testing shows that, when cleaned regularly, antimicrobial copper, like MD-Cu29, kills greater than 99.9% of bacteria* within 2 hours of exposure.

*Vancomycin-Resistant Enterococcus faecalis (VRE), Methicillin-Resistant Staphylococcus aureus (MRSA), Enterobacter aerogenes, Pseudomonas aeruginosa, and Escherichia coli O157:H7.

Antimicrobial copper surfaces, made with materials such as MD-Cu29, are a supplement to and not a substitute for standard infection control practices and have been shown to reduce microbial contamination, but do not necessarily prevent cross contamination; users must continue to follow all current infection control practices.

Logo - http://photos.prnewswire.com/prnh/20140109/NE43441LOGO


'/>"/>
SOURCE Hussey Copper
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Quammen Health Care Consultants Takes Over Information Technology Reins at Faith Regional Health Services
2. Registration now open: 2012 Regional, State, and Local Initiatives in Nanotechnology
3. All Market Research New Report @ The Worldwide Industry & Regional Market Opportunities With Forecasts to 2016 for Amplifiers and Integrated Microwave Assemblies. (Code name: AIMAs)
4. Governor Cuomo Announces Continued Growth at Roswell Park Cancer Institute with Regional Economic Development Council Funding; RPCI Center for Personalized Medicine established with CTG (NASDAQ: CTGX) serving as its technology partner
5. Surveyed U.S. Payers Are Significantly More Likely To Reimburse Biosimilars Developed By Multinational Manufacturers Compared With Those Developed By Regional Emerging Market Players
6. Grace Century, FZ LLC Publishes Annual Global and Regional Financial Predications for 2014
7. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
8. Antelope Valley Hospital Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities
9. What Hospitals Must Do to Thrive -- Not Just Survive -- on Medicare Margins
10. Meaningful Use Stage Two: The Advisory Board Company Helps Hospitals Set Strategy
11. Biotech Firm Spun Off from Childrens Hospital Raises $7 Million to Advance Magnetic-Based Vascular Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... 03, 2016 , ... Morf Media Inc ., developer ... on mobile devices, today released a new interactive Food and Drug Administration ... course is essential for owners or operators of places of business that are ...
(Date:5/3/2016)... , ... May 03, 2016 , ... ... the addition of Dr. Nancy Gillett to its Board of Directors. Dr. Gillett ... served as Corporate Executive Vice President and Chief Scientific Officer. A board-certified veterinary ...
(Date:5/3/2016)... 2016 - And Other Rising ... of Those Competitor Biologics  - Biosimilar Drug ... Prospects ,  Who are the most important ... are their sales potentials? Discover, in our updated survey, ... opportunities and revenue forecasting. Visiongain,s ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... clinics and IVF laboratories. A contingency of reproductive endocrinologists, including Dr. George ... women experiencing infertility and to help them build families. , Ovation Fertility is ...
Breaking Biology Technology:
(Date:3/8/2016)...   Valencell , the leading innovator in ... secured $11M in Series D financing. The investment ... fund being launched by UAE-based financial services company ... TDF Ventures and WSJ Joshua Fund. Valencell plans ... growth and accelerate its pioneering innovation in accurate ...
(Date:3/3/2016)... DE SOTO, Kansas , March 3, ... Plus® to offer Oncimmune,s Early CDT®-Lung, a blood ... detection of lung cancer Early CDT®-Lung test ... individuals. --> Early CDT®-Lung test to its ... --> Oncimmune, a leader in early cancer detection, ...
(Date:3/1/2016)... March 1, 2016 ... addition of the  "Global Biometric Access ... to their offering. --> ... of the  "Global Biometric Access Control ... their offering. --> Research ...
Breaking Biology News(10 mins):